Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St. Jude Venture catheter

This article was originally published in The Gray Sheet

Executive Summary

Firm gains 510(k) clearance for its Venture wire control catheter for use with a rapid exchange delivery platform. The rapid exchange delivery method accommodates shorter guidewires, which may result in quicker, easier coronary procedures, the firm says. The Venture catheter, first approved in 2005 for use with an over-the-wire system, features a deflectable tip, allowing interventional cardiologists to treat difficult-to-reach areas in the heart. St. Jude obtained Venture in its 2005 acquisition of Velocimed (1"The Gray Sheet" Feb. 21, 2005, p. 9)...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts